|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 美泊利单抗>> 市场分析报告 |
美泊利单抗市场分析报告 |
|
Meperidine (CAS 196078-29-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Mesoridazine (base and/or unspecified salts) (CAS 5588-33-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Meropenem (Injection) (CAS 96036-03-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Meropenem (CAS 96036-03-2) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS). Targeted Therapies in Asthma: KOL Insight [2018] ... see this class evolving? Nucala (mepolizumab) was the first mAb to receive ... Xolair (omalizumab; Roche/Novartis) Nucala (mepolizumab; GSK) Cinqair/Cinqaero (reslizumab, Teva ... COPD [2017] ... Therapies (Phase II/III) benralizumab (AstraZeneca) mepolizumab (GSK) budesonide/formoterol/glycopyrrolate (PT010 ... Atopic Dermatitis [2017] ... Moreover, other pipeline programmes, including mepolizumab (anti-IL-5; GSK) and nemolizumab ... any reservations about clinical similarity? Mepolizumab (anti-IL-5; GSK) and nemolizumab ... ) Lebrikizumab (anti-IL13; Dermira) Mepolizumab (anti-IL5; GSK) Nemolizumab ( ... Global Hypereosinophilic Syndrome Drug Market Report 2020 ... Segmentation Benralizumab Dasatinib Dexpramipexole Dihydrochloride Mepolizumab Industry Segmentation Research Center Hospital ... Global Hypereosinophilic Syndrome Drug Industry Research Report 2020, Forecast to 2025 ... by types: Benralizumab Dasatinib Dexpramipexole Dihydrochloride Mepolizumab Others It can be also divided by applications ... Global Hypereosinophilic Syndrome Drug Market Insight 2020, Forecast to 2025 ... by types: Benralizumab Dasatinib Dexpramipexole Dihydrochloride Mepolizumab Others It can be also divided by applications ... Global Eosinophilic Granulomatosis Treatment Market Growth (Status and Outlook) 2023-2029 ... Segmentation: Segmentation by type By Drug Type Mepolizumab Rituximab Benralizumab Omalizumab Methotrexate Sodium ... Global Hypereosinophilic Syndrome Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 ... , covers Benralizumab Dasatinib Dexpramipexole Dihydrochloride Mepolizumab Others Market segment by Application can ... Eosinophilic Granulomatosis Treatment Market, Global Outlook and Forecast 2022-2028 ... Percentages, by Type, 2021 (%) By Drug Type Mepolizumab Rituximab Benralizumab Omalizumab Methotrexate Sodium ... Global Hypereosinophilic Syndrome Drug Market Growth 2025-2031 ... by Type: Benralizumab Dasatinib Dexpramipexole Dihydrochloride Mepolizumab Others Segmentation by Application: Research Center ... Hypereosinophilic Syndrome Drug Market, Global Outlook and Forecast 2022-2028 ... , 2021 (%) Benralizumab Dasatinib Dexpramipexole Dihydrochloride Mepolizumab Others Global Hypereosinophilic Syndrome Drug ... Global Biologics for CRSwNP Market Growth 2024-2030 ... and countries. Segmentation by Type: Dupilumab Mepolizumab Omalizumab Segmentation by Application: Hospital Clinic ... Global Biologics for Severe Asthma Market Growth 2024-2030 ... . Segmentation by Type: Omalizumab Benralizumab Dupirumab Mepolizumab Reslizumab Tezepelumab-ekko Segmentation by Application ... 2025-2030 Global Biologics for CRSwNP Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region ... GSK Genentech Novartis By Type Dupilumab Mepolizumab Omalizumab By Application Hospital Clinic Other ... 2025-2030 Global Biologics for Severe Asthma Outlook Market Size, Share & Trends Analysis Report By Player, Type, Application and Region ... Pharmaceuticals By Type Omalizumab Benralizumab Dupirumab Mepolizumab Reslizumab Tezepelumab-ekko By Application Hospital ... Global Pharma US & EU Outlook 2015: First –In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition In the recent years several new therapies have been approved in the area of ... |